China · 
Who invested in Accro Bioscience?
Accro Bioscience's investors include Shenzhen Capital Group Co., Oriza Holdings, OrbiMed, Morningside Group and 5Y Capital, and 4 more on record. OrbiMed led its latest round.
2026
$14MSeries B$50MSeries CChina · Series C startup
Who invested in Accro Bioscience
2 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 6 months ago
Follow Accro Bioscience and see its new rounds in your feed. Start following
Funding summaryUpdated 5 Nov 2026
$64Mraised across 2 rounds since 2025, from 2 sources
$14MSeries B$50MSeries C
- Latest round
- Series C, $50MMay 2026
- Led by
- OrbiMed
- Step-upi
- 3.6×
- Investors
- 9 (1 led)
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series B, $14M Mar 2025
- Biggest round
- $50M Series C · May 2026
- Between rounds
- 15 months from the last two
The rounds
- May 2026Series C$50M4 new2 returning
Reported by Ventureburn
- Mar 2025Series B$14M5 new
Source recorded
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
LAVGrowth equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Accro Bioscience
How much has Accro Bioscience raised?
Accro Bioscience has raised $64M across 2 rounds since 2025.
When did Accro Bioscience last raise?
Accro Bioscience's most recent round was a Series C of $50M in May 2026, led by OrbiMed.
What was Accro Bioscience's biggest round?
Its most recent round, $50M in May 2026, is also its largest on record.
Who backed Accro Bioscience first?
Accro Bioscience's first round on record, in Mar 2025, was backed by Shenzhen Capital Group Co., Morningside Group and 5Y Capital and 2 others.
What stage is Accro Bioscience at?
Accro Bioscience's latest named round is a Series C, in May 2026.
Where is Accro Bioscience based?
Accro Bioscience is based in China.
Who led Accro Bioscience's rounds?
OrbiMed led the Series C in 2026.
Companies like Accro Bioscience
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.